BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1763794)

  • 1. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
    Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
    Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to antimicrobial therapy for shigellosis in Thailand.
    Lolekha S; Vibulbandhitkit S; Poonyarit P
    Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
    Salam MA; Bennish ML
    J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
    Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
    Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
    Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
    J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
    Gotuzzo E; Oberhelman RA; MaguiƱa C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nalidixic acid for shigellosis.
    Parry HE
    Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
    Bassily S; Hyams KC; el-Masry NA; Farid Z; Cross E; Bourgeois AL; Ayad E; Hibbs RG
    Am J Trop Med Hyg; 1994 Aug; 51(2):219-23. PubMed ID: 8074256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
    Islam MR; Alam AN; Hussain MS; Mahalanabis D
    J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study of wintomylon in the treatment of shigellosis.
    Yu PC; Chen HS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
    Haltalin KC; Nelson JD; Kusmiesz HT
    Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics in the management of shigellosis.
    Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
    [No Abstract]   [Full Text] [Related]  

  • 20. Nalidixic acid for shigellosis.
    McCormack JG
    Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.